• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦两个郡肌萎缩侧索硬化症患者的生存率

Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties.

作者信息

Christensen P B, Højer-Pedersen E, Jensen N B

机构信息

Department of Neurology, Aalborg Hospital, Denmark.

出版信息

Neurology. 1990 Apr;40(4):600-4. doi: 10.1212/wnl.40.4.600.

DOI:10.1212/wnl.40.4.600
PMID:2320232
Abstract

We investigated the survival of patients with amyotrophic lateral sclerosis (ALS) in a follow-up study of all patients hospitalized with the disease in 2 Danish counties during the period 1974 to 1986. There were 186 patients, with a mean age at diagnosis of 64.3 years. The median survival time was 12 months from diagnosis, the 3-year survival rate was 12%, and the 5-year survival rate 4%. (The corresponding figures from onset were 23 months, 26%, and 7%). Old age and bulbar findings at onset were negative prognostic factors. For each clinical category, the annual death rate remained constant throughout the observation period, indicating the effects of a steadily progressing degenerative disorder. We found no evidence of the existence of a separate variety of ALS, associated with long survival.

摘要

在一项针对1974年至1986年期间丹麦两个县所有因肌萎缩侧索硬化症(ALS)住院患者的随访研究中,我们调查了患者的生存率。共有186例患者,诊断时的平均年龄为64.3岁。从诊断开始的中位生存时间为12个月,3年生存率为12%,5年生存率为4%。(从发病开始的相应数字分别为23个月、26%和7%)。老年和发病时出现延髓症状是不良预后因素。对于每个临床类别,在整个观察期内年死亡率保持恒定,表明存在一种进行性退化性疾病。我们没有发现存在与长期生存相关的单独类型ALS的证据。

相似文献

1
Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties.丹麦两个郡肌萎缩侧索硬化症患者的生存率
Neurology. 1990 Apr;40(4):600-4. doi: 10.1212/wnl.40.4.600.
2
[Survival in amyotrophic lateral sclerosis].[肌萎缩侧索硬化症的生存情况]
Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):19-23.
3
Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.中国散发性肌萎缩侧索硬化的自然史和临床特征。
J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1075-81. doi: 10.1136/jnnp-2015-310471. Epub 2015 Jun 29.
4
Survival of patients with amyotrophic lateral sclerosis in a population-based registry.基于人群登记系统的肌萎缩侧索硬化症患者生存率
Neuroepidemiology. 2005;25(3):114-9. doi: 10.1159/000086353. Epub 2005 Jun 13.
5
Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.1153例肌萎缩侧索硬化症患者的临床特征与生存模式:来自印度30多年的经验
J Neurol Sci. 2008 Sep 15;272(1-2):60-70. doi: 10.1016/j.jns.2008.04.034. Epub 2008 Jun 12.
6
Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.1966年至2005年日本和歌山县肌萎缩侧索硬化症患者的生存率
J Neurol Sci. 2008 May 15;268(1-2):95-101. doi: 10.1016/j.jns.2007.11.011. Epub 2007 Dec 31.
7
Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.利鲁唑与肌萎缩侧索硬化症患者的生存情况:意大利南部的一项基于人群的研究。
Eur J Neurol. 2007 Mar;14(3):262-8. doi: 10.1111/j.1468-1331.2006.01575.x.
8
Long-term survival in amyotrophic lateral sclerosis: a population-based study.肌萎缩侧索硬化症的长期生存:一项基于人群的研究。
Ann Neurol. 2014 Feb;75(2):287-97. doi: 10.1002/ana.24096. Epub 2014 Feb 24.
9
Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium.肌萎缩侧索硬化症:疾病过程中的死亡风险及预后因素。荷兰肌萎缩侧索硬化症研究联盟。
J Neurol Sci. 1997 Oct;152 Suppl 1:S10-7. doi: 10.1016/s0022-510x(97)00238-4.
10
Predicting the duration of Guam amyotrophic lateral sclerosis.预测关岛肌萎缩侧索硬化症的病程。
Neurology. 1975 Mar;25(3):277-80. doi: 10.1212/wnl.25.3.277.

引用本文的文献

1
Impact of Limb Phenotype on Tongue Denervation Atrophy, Dysphagia Penetrance, and Survival Time in a Mouse Model of ALS.肢体表型对 ALS 小鼠模型中舌神经切断萎缩、吞咽困难发生率和生存时间的影响。
Dysphagia. 2022 Dec;37(6):1777-1795. doi: 10.1007/s00455-022-10442-4. Epub 2022 Apr 15.
2
Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery.优化肌萎缩侧索硬化症(ALS)小鼠模型的转化价值,以促进吞咽障碍治疗的发现。
Dysphagia. 2020 Apr;35(2):343-359. doi: 10.1007/s00455-019-10034-9. Epub 2019 Jul 12.
3
Therapeutic effects of percutaneous endoscopic gastrostomy on survival in patients with amyotrophic lateral sclerosis: A meta-analysis.
经皮内镜下胃造口术对肌萎缩侧索硬化症患者生存的治疗效果:一项荟萃分析。
PLoS One. 2018 Feb 6;13(2):e0192243. doi: 10.1371/journal.pone.0192243. eCollection 2018.
4
Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.肌萎缩侧索硬化症全球发病率的差异:一项荟萃分析。
Int J Epidemiol. 2017 Feb 1;46(1):57-74. doi: 10.1093/ije/dyw061.
5
Stratification of ALS patients' survival: a population-based study.肌萎缩侧索硬化症患者生存情况分层:一项基于人群的研究。
J Neurol. 2016 Jan;263(1):100-11. doi: 10.1007/s00415-015-7940-z. Epub 2015 Oct 30.
6
Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.与人口祖籍有关的肌萎缩侧索硬化的临床和人口统计学因素及结果。
Eur J Epidemiol. 2016 Mar;31(3):229-45. doi: 10.1007/s10654-015-0090-x. Epub 2015 Oct 12.
7
Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?在没有传导阻滞的进行性下运动神经元综合征中,是否需要 IVIg 治疗?
Neurology. 2013 Dec 10;81(24):2116-20. doi: 10.1212/01.wnl.0000437301.28441.7e. Epub 2013 Nov 8.
8
Exercise and amyotrophic lateral sclerosis.运动与肌萎缩侧索硬化。
Neurol Sci. 2012 Feb;33(1):9-15. doi: 10.1007/s10072-011-0921-9. Epub 2012 Jan 7.
9
Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.1925年至2004年在奥尔姆斯特德县患肌萎缩侧索硬化症存活5年及以上的患者。
J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1144-6. doi: 10.1136/jnnp.2009.201251. Epub 2010 Jul 13.
10
Prognostic factors in ALS: A critical review.肌萎缩侧索硬化症的预后因素:一项批判性综述。
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):310-23. doi: 10.3109/17482960802566824.